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Reviewer of the month e October 2012: Jim McCaulJim McCaul is a Consultant Maxillofacial/Head and Neck
Surgeon in Bradford Teaching Hospitals NHS Foundation Trust. He
is also lead for research and Clinical Trials inMaxillofacial/Head and
Neck Surgery and holds research positions at the Institute for
Cancer Therapeutics (ICT) in the University of Bradford and the
Leeds Institute forMolecular Medicine. He is a boardmember of the
Ethical Tissue Collection Bank at the University of Bradford ICT. He
is Head and Neck research lead for Yorkshire Cancer Network and
Specialty Chair for the Comprehensive Clinical Research Network of
the National Institute for Health Research.
He studied medicine and dentistry both at the University of
Glasgowgraduatedwith Honours in both degrees. After completion
of the West of Scotland Basic surgical training scheme he obtained
FDSRCPS and then FRCS examinations. He then trained in the West
of Scotland Maxillofacial programme and also spent time in Miami
and London. He completed his doctoral work in the CRUK Beatson
Institute for Cancer Research graduating PhD in 2005. He is the
author four book chapters and over 40 publications in the ﬁeld
including papers in Lancet Oncology, Cancer research, Oral
Oncology and the British Journal of Oral and Maxillofacial Surgery.
His work on telomere biology in Head and Neck Cancer won the
Scottish Oral and Maxillofacial Society prize on three occasions and
the golden award at the 2nd European Head and Neck Cancer
Conference in Lille.
He leads a research team of seven in Bradford and is Chief
investigator for the LIHNCS trial funded by Cancer Research UK and
for the Supportive Care Follow up study funded by Macmillan
Cancer Support. In addition he is Co-Investigator in three other
randomized controlled trials and site Principle Investigator for
another eight clinical trials. He is Since 2004 he has been a member
of the Advanced Craniomaxillofacial Forum Technical Advisory
Committee. He is a Section Editor for the British Journal of Oral and
Maxillofacial Surgery and reviews for a number of other.
His Clinical work in Maxillofacial/Head and Neck Surgery is
focused on early diagnosis and resection and free ﬂap reconstruc-
tion for head and neck cancer with emphasis on functional
outcomes for life after cancer.1743-9191/$ e see front matter
doi:10.1016/j.ijsu.2012.04.006Research clinical interests include the use of Lugol’s Iodine to
reduce margin dysplasia at cancer resection margins (LIHNCS trial),
the role for intraoperative optimization in major head and neck
cancer surgery and novel patterns for follow up in head and neck
cancer patients. His laboratory collaborations include work on
chemokine inhibitors to reduce metastasis rates and mass spec-
troscopy analysis of novel cancer targets for small molecule
inhibitors with the Institute for Cancer Therapeutics at the
University of Bradford. He collaborates with the Leeds Institute for
Molecular Medicine on gene copy number analysis and the
University of Glasgow on Sirtuin proteins.
